Published on February 17, 2025, 01:03 PM UTC
Hims & Hers (HIMS) stock plunged 26% on Tuesday despite a better-than-expected Q4 report, as investors worry about potential revenue loss from discontinued compounded weight-loss drugs. CFO Yemi Okupe downplayed these concerns, highlighting the company's diversified revenue stream and strong outlook for 2024, but Wall Street remains cautious amid industry-wide changes in semaglutide availability.
Published on: February 25, 2025, 05:01 PM UTC
South Carolina is a top destination for out-of-state moves, with a booming population and job market, attracting residents seeking a warmer climate, lower cost of living, and coastal communities.
Published on: February 22, 2025, 06:01 PM UTC
Japan's Seven & i Holdings picks Bain Capital to buy stake in non-core unit York Holdings, reportedly for over $4.7 billion.
Published on: February 22, 2025, 11:00 AM UTC
Central bankers' speeches and policy statements are quickly influencing asset prices due to AI, boosting monetary policy transmission but raising concerns about accuracy and informativeness.
Published on: February 21, 2025, 05:00 PM UTC
Valuations for tech giants like Meta, Amazon, and Google remain high, tempering future return expectations. Diversification is crucial, with investors urged to broaden portfolios beyond the "Magnificent Seven" tech stocks.
Published on: February 21, 2025, 04:03 PM UTC